1 January 2024 false No description of principal activity Taxfiler 2024.6 12374002business:PrivateLimitedCompanyLtd2024-01-012024-12-31 123740022023-12-31 123740022024-01-012024-12-31 12374002business:AuditExempt-NoAccountantsReport2024-01-012024-12-31 12374002business:FilletedAccounts2024-01-012024-12-31 123740022024-12-31 12374002business:Director12024-01-012024-12-31 12374002business:RegisteredOffice2024-01-012024-12-31 123740022023-12-31 12374002core:WithinOneYear2024-12-31 12374002core:WithinOneYear2023-12-31 12374002core:AfterOneYear2024-12-31 12374002core:AfterOneYear2023-12-31 12374002core:ShareCapitalcore:PreviouslyStatedAmount2024-12-31 12374002core:ShareCapitalcore:PreviouslyStatedAmount2023-12-31 12374002core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-12-31 12374002core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-12-31 12374002core:PreviouslyStatedAmount2024-12-31 12374002core:PreviouslyStatedAmount2023-12-31 12374002business:SmallEntities2024-01-012024-12-31 12374002countries:EnglandWales2024-01-012024-12-31 12374002core:FurnitureFittings2024-01-012024-12-31 12374002core:ComputerEquipment2024-01-012024-12-31 12374002core:FurnitureFittings2023-12-31 12374002core:ComputerEquipment2023-12-31 12374002core:FurnitureFittings2024-12-31 12374002core:ComputerEquipment2024-12-31 12374002business:OrdinaryShareClass12024-01-012024-12-31 12374002business:OrdinaryShareClass12023-01-012023-12-31 123740022023-01-012023-12-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 12374002 (England and Wales)
CURAID MEDICAL LIMITED Unaudited accounts for the year ended 31 December 2024
CURAID MEDICAL LIMITED Unaudited accounts Contents
Page
- 2 -
CURAID MEDICAL LIMITED Company Information for the year ended 31 December 2024
Director
Dr Amal El-Hawari
Company Number
12374002 (England and Wales)
Registered Office
53 CANFORD LANE BRISTOL BS9 3NX ENGLAND
Accountants
Fabaci Financial Ltd 30 Ebbett Court Victoria Road London W3 6BW
- 3 -
CURAID MEDICAL LIMITED Statement of financial position as at 31 December 2024
2024 
2023 
Notes
£ 
£ 
Fixed assets
Tangible assets
7,869 
6,080 
Current assets
Debtors
45,000 
35,539 
Cash at bank and in hand
6,076 
10,595 
51,076 
46,134 
Creditors: amounts falling due within one year
(41,983)
(51,813)
Net current assets/(liabilities)
9,093 
(5,679)
Total assets less current liabilities
16,962 
401 
Creditors: amounts falling due after more than one year
(15,767)
- 
Net assets
1,195 
401 
Capital and reserves
Called up share capital
100 
100 
Profit and loss account
1,095 
301 
Shareholders' funds
1,195 
401 
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 29 December 2025 and were signed on its behalf by
Dr Amal El-Hawari Director Company Registration No. 12374002
- 4 -
CURAID MEDICAL LIMITED Notes to the Accounts for the year ended 31 December 2024
1
Statutory information
CURAID MEDICAL LIMITED is a private company, limited by shares, registered in England and Wales, registration number 12374002. The registered office is 53 CANFORD LANE, BRISTOL, BS9 3NX, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in British pound sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
25% Straight Line Method
Computer equipment
25% Straight Line Method
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts and rebates. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign exchange
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rates of exchange ruling at the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
Financial instruments
Basic financial instruments are recognised at amortised cost, except for investments in non-convertible preference and non-puttable ordinary shares which are measured at fair value, with changes recognised in profit or loss. Derivative financial instruments are initially recorded at cost and thereafter at fair value with changes recognised in profit or loss.
- 5 -
CURAID MEDICAL LIMITED Notes to the Accounts for the year ended 31 December 2024
4
Tangible fixed assets
Fixtures & fittings 
Computer equipment 
Total 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At 1 January 2024
3,000 
6,160 
9,160 
Additions
- 
4,449 
4,449 
At 31 December 2024
3,000 
10,609 
13,609 
Depreciation
At 1 January 2024
750 
2,330 
3,080 
Charge for the year
750 
1,910 
2,660 
At 31 December 2024
1,500 
4,240 
5,740 
Net book value
At 31 December 2024
1,500 
6,369 
7,869 
At 31 December 2023
2,250 
3,830 
6,080 
5
Debtors
2024 
2023 
£ 
£ 
Amounts falling due within one year
Other debtors
45,000 
35,539 
6
Creditors: amounts falling due within one year
2024 
2023 
£ 
£ 
Bank loans and overdrafts
5,460 
25,000 
Taxes and social security
30,877 
26,033 
Loans from directors
4,866 
- 
Accruals
780 
780 
41,983 
51,813 
7
Creditors: amounts falling due after more than one year
2024 
2023 
£ 
£ 
Bank loans
15,767 
- 
8
Share capital
2024 
2023 
£ 
£ 
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100 
100 
9
Average number of employees
During the year the average number of employees was 1 (2023: 1).
- 6 -